Homepage2019-12-16T16:15:39+00:00

E²-RADIatE

THE NEW PLATFORM FOR RADIOTHERAPY

E²-RADIatE (EORTC 1811 study) is a platform that collects real-world data through prospective data registries in radiotherapy. A collaboration between the European Organisation for Research and Treatment of Cancer (EORTC) and the European Society for Radiotherapy and Oncology (ESTRO), it aims to be a pan-European infrastructure and a more efficient framework across the field of radiation oncology to generate robust data in cancer treatment and to further develop and integrate the discipline into therapeutic strategies.

E²-RADIatE is an observational prospective multi-cohort study that will be able to answer questions stemming from current and future cohorts. The data will support radiotherapy research and provide evidence of the role of radiation oncology in a multidisciplinary approach. The study will be activated in both non-academic and academic centres.

Read more

News & Publications

View all

Why participate?

When you participate in E²-RADIatE, you will be given several rights and privileges.

Join us
Go to Top